107 related articles for article (PubMed ID: 10575525)
1. A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens.
Razvi K; Sonoda K; Lee YS; Tham KF; Lim FK; Yong EL
Ann Acad Med Singap; 1999 May; 28(3):392-4. PubMed ID: 10575525
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
Ohwada M; Suzuki M; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and ultrastructural investigation of new membrane-associated placental tissue proteins (MP2 A, B, C, D, and E) in gynecologic neoplasms.
Hirai Y; Inaba N; Takamizawa H; Chen JT; Hasumi K; Masubuchi K; Bohn H; Suemizu H; Osamura Y; Watanabe K
Asia Oceania J Obstet Gynaecol; 1992 Sep; 18(3):245-53. PubMed ID: 1449425
[TBL] [Abstract][Full Text] [Related]
6. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6.
Smith NL; Halliday BE; Finley JL; Wennerberg AE
Int J Gynecol Pathol; 2001 Jul; 20(3):260-6. PubMed ID: 11444202
[TBL] [Abstract][Full Text] [Related]
9. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
10. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
Ferguson A; Moore M; Fox H
Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of colon-ovarian tumor antigen and colon-specific antigen in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Tanaka Y; Inoue M; Tanizawa O
Gynecol Oncol; 1989 Oct; 35(1):90-2. PubMed ID: 2792910
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and mixed epithelial tumors of the endometrium.
O'Leary JJ; Landers RJ; Crowley M; Healy I; O'Donovan M; Healy V; Kealy WF; Hogan J; Doyle CT
Hum Pathol; 1998 Apr; 29(4):383-9. PubMed ID: 9563789
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of MUC genes in endometrial and cervical tissues and tumors.
Hebbar V; Damera G; Sachdev GP
BMC Cancer; 2005 Sep; 5():124. PubMed ID: 16188033
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
16. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Scharl A; Crombach G; Vierbuchen M; Müsch H; Bolte A
Arch Gynecol Obstet; 1989; 244(2):103-12. PubMed ID: 2712596
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma.
McCluggage WG; Maxwell P; Veenstra H; Fick CE; Laeng RH; Tiltman AJ
Histopathology; 2001 Jun; 38(6):542-9. PubMed ID: 11422498
[TBL] [Abstract][Full Text] [Related]
18. Distribution of colon-ovarian tumor antigen in adenocarcinomas. An immunohistochemical study of 501 cases.
Loy TS; Darkow GV
Am J Clin Pathol; 1993 Feb; 99(2):207-10. PubMed ID: 7679875
[TBL] [Abstract][Full Text] [Related]
19. Expression of a local immune defense system in the female genital tract. An immunohistochemical study.
Kondi-Paphitis A; Carvounis H; Kairi E; Frangou M; Papayanopoulou A; Deligeorgi H
Eur J Gynaecol Oncol; 1999; 20(2):141-3. PubMed ID: 10376434
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
